Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronika Sarosi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pathology Oncology Research : POR|September 18, 2010
PET-CT imaging and realityZoltan Baliko, Veronika Sarosi, Miklos Balazs Illes, et al.
Frontiers in Immunology|August 10, 2018
Cigarette Smoke-Induced Pulmonary Inflammation Becomes Systemic by Circulating Extracellular Vesicles Containing Wnt5a and Inflammatory CytokinesDiana Feller, Jozsef Kun, Istvan Ruzsics, et al.
Lung Cancer (Amsterdam, Netherlands)|August 18, 2014
Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE)Veronika Sarosi, Gyorgy Losonczy, Eva Francovszky, et al.
COPD|October 31, 2015
L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential BiomarkerIstvan Ruzsics, Lajos Nagy, Sandor Keki, et al.
Respiratory Research|April 13, 2025
Serum and exosome WNT5A levels as biomarkers in non-small cell lung cancerZsofia Torok, Kitti Garai, Judit Bovari-Biri, et al.
International Journal of Molecular Sciences|June 2, 2021
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung CancerLuca Jaromi, Veronika Csongei, Monika Vesel, et al.
Aging Cell|July 2, 2014
Alteration in the Wnt microenvironment directly regulates molecular events leading to pulmonary senescenceTamas Kovacs, Veronika Csongei, Diana Feller, et al.
Respiratory Research|May 22, 2020
Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent mannerEdit Kiss, El Husseiny Mohamed Mahmud Abdelwahab, Anita Steib, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pathology Oncology Research : POR|September 18, 2010
PET-CT imaging and realityZoltan Baliko, Veronika Sarosi, Miklos Balazs Illes, et al.
Frontiers in Immunology|August 10, 2018
Cigarette Smoke-Induced Pulmonary Inflammation Becomes Systemic by Circulating Extracellular Vesicles Containing Wnt5a and Inflammatory CytokinesDiana Feller, Jozsef Kun, Istvan Ruzsics, et al.
Lung Cancer (Amsterdam, Netherlands)|August 18, 2014
Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE)Veronika Sarosi, Gyorgy Losonczy, Eva Francovszky, et al.
COPD|October 31, 2015
L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential BiomarkerIstvan Ruzsics, Lajos Nagy, Sandor Keki, et al.
Respiratory Research|April 13, 2025
Serum and exosome WNT5A levels as biomarkers in non-small cell lung cancerZsofia Torok, Kitti Garai, Judit Bovari-Biri, et al.
International Journal of Molecular Sciences|June 2, 2021
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung CancerLuca Jaromi, Veronika Csongei, Monika Vesel, et al.
Aging Cell|July 2, 2014
Alteration in the Wnt microenvironment directly regulates molecular events leading to pulmonary senescenceTamas Kovacs, Veronika Csongei, Diana Feller, et al.
Respiratory Research|May 22, 2020
Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent mannerEdit Kiss, El Husseiny Mohamed Mahmud Abdelwahab, Anita Steib, et al.
Pageof 1